AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis

NYSE:AMN • US0017441017

16.39 USD
+0.14 (+0.86%)
At close: Feb 17, 2026
16.45 USD
+0.06 (+0.37%)
After Hours: 2/17/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

AMN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. AMN has only an average score on both its financial health and profitability. AMN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • AMN had positive earnings in the past year.
  • In the past year AMN had a positive cash flow from operations.
  • Of the past 5 years AMN 4 years were profitable.
  • In the past 5 years AMN always reported a positive cash flow from operatings.
AMN Yearly Net Income VS EBIT VS OCF VS FCFAMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • AMN has a Return On Assets of -12.88%. This is in the lower half of the industry: AMN underperforms 77.45% of its industry peers.
  • Looking at the Return On Equity, with a value of -42.76%, AMN is doing worse than 71.57% of the companies in the same industry.
  • AMN has a Return On Invested Capital of 2.08%. This is comparable to the rest of the industry: AMN outperforms 45.10% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for AMN is above the industry average of 8.98%.
  • The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.08%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -12.88%
ROE -42.76%
ROIC 2.08%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
AMN Yearly ROA, ROE, ROICAMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • With a Operating Margin value of 1.65%, AMN perfoms like the industry average, outperforming 46.08% of the companies in the same industry.
  • AMN's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 29.37%, AMN perfoms like the industry average, outperforming 58.82% of the companies in the same industry.
  • AMN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.65%
PM (TTM) N/A
GM 29.37%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
AMN Yearly Profit, Operating, Gross MarginsAMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • AMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • AMN has more shares outstanding than it did 1 year ago.
  • AMN has less shares outstanding than it did 5 years ago.
  • AMN has a better debt/assets ratio than last year.
AMN Yearly Shares OutstandingAMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AMN Yearly Total Debt VS Total AssetsAMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.40 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • AMN has a Altman-Z score (2.40) which is comparable to the rest of the industry.
  • AMN has a debt to FCF ratio of 3.80. This is a good value and a sign of high solvency as AMN would need 3.80 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 3.80, AMN is in the better half of the industry, outperforming 71.57% of the companies in the same industry.
  • AMN has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.31, AMN is not doing good in the industry: 65.69% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.8
Altman-Z 2.4
ROIC/WACC0.28
WACC7.54%
AMN Yearly LT Debt VS Equity VS FCFAMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
  • The Current ratio of AMN (1.05) is worse than 66.67% of its industry peers.
  • AMN has a Quick Ratio of 1.05. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.05, AMN is doing worse than 60.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
AMN Yearly Current Assets VS Current LiabilitesAMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for AMN have decreased strongly by -51.29% in the last year.
  • The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
  • Looking at the last year, AMN shows a very negative growth in Revenue. The Revenue has decreased by -11.42% in the last year.
  • AMN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.07% yearly.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%

3.2 Future

  • Based on estimates for the next years, AMN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.82% on average per year.
  • The Revenue is expected to grow by 4.40% on average over the next years.
EPS Next Y-57.04%
EPS Next 2Y-54.6%
EPS Next 3Y-30.54%
EPS Next 5Y22.82%
Revenue Next Year-8.07%
Revenue Next 2Y-6.86%
Revenue Next 3Y-3.35%
Revenue Next 5Y4.4%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMN Yearly Revenue VS EstimatesAMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
AMN Yearly EPS VS EstimatesAMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 8.67 indicates a reasonable valuation of AMN.
  • Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 94.12% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of AMN to the average of the S&P500 Index (27.16), we can say AMN is valued rather cheaply.
  • The Price/Forward Earnings ratio is 24.02, which indicates a rather expensive current valuation of AMN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AMN is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 28.10. AMN is around the same levels.
Industry RankSector Rank
PE 8.67
Fwd PE 24.02
AMN Price Earnings VS Forward Price EarningsAMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 86.27% of the companies listed in the same industry.
  • 99.02% of the companies in the same industry are more expensive than AMN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.83
EV/EBITDA 6.92
AMN Per share dataAMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • A cheap valuation may be justified as AMN's earnings are expected to decrease with -30.54% in the coming years.
PEG (NY)N/A
PEG (5Y)10.78
EPS Next 2Y-54.6%
EPS Next 3Y-30.54%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AMN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMN HEALTHCARE SERVICES INC

NYSE:AMN (2/17/2026, 8:04:00 PM)

After market: 16.45 +0.06 (+0.37%)

16.39

+0.14 (+0.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners109.44%
Inst Owner Change-2.09%
Ins Owners0.45%
Ins Owner Change9.04%
Market Cap629.54M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target21.27 (29.77%)
Short Float %5.11%
Short Ratio1.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)2.1%
PT rev (3m)1.39%
EPS NQ rev (1m)2.3%
EPS NQ rev (3m)24.26%
EPS NY rev (1m)2.26%
EPS NY rev (3m)23.61%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.59%
Valuation
Industry RankSector Rank
PE 8.67
Fwd PE 24.02
P/S 0.23
P/FCF 2.83
P/OCF 2.36
P/B 0.98
P/tB N/A
EV/EBITDA 6.92
EPS(TTM)1.89
EY11.53%
EPS(NY)0.68
Fwd EY4.16%
FCF(TTM)5.8
FCFY35.39%
OCF(TTM)6.94
OCFY42.36%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)10.78
Graham Number26.71
Profitability
Industry RankSector Rank
ROA -12.88%
ROE -42.76%
ROCE 2.81%
ROIC 2.08%
ROICexc 2.16%
ROICexgc 6.84%
OM 1.65%
PM (TTM) N/A
GM 29.37%
FCFM 8.2%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.8
Debt/EBITDA 4.12
Cap/Depr 27.3%
Cap/Sales 1.62%
Interest Coverage 0.95
Cash Conversion 129.62%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 2.4
F-Score4
WACC7.54%
ROIC/WACC0.28
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-57.04%
EPS Next 2Y-54.6%
EPS Next 3Y-30.54%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-8.07%
Revenue Next 2Y-6.86%
Revenue Next 3Y-3.35%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y20.38%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%

AMN HEALTHCARE SERVICES INC / AMN FAQ

What is the fundamental rating for AMN stock?

ChartMill assigns a fundamental rating of 4 / 10 to AMN.


Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?

ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.


How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?

AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.


What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?

The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to decline by -57.04% in the next year.